BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25382874)

  • 1. Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.
    Carroll V; Demoin DW; Hoffman TJ; Jurisson SS
    Radiochim Acta; 2012 Aug; 100(8-9):653-667. PubMed ID: 25382874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matching chelators to radiometals for radiopharmaceuticals.
    Price EW; Orvig C
    Chem Soc Rev; 2014 Jan; 43(1):260-90. PubMed ID: 24173525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases.
    Sarko D; Eisenhut M; Haberkorn U; Mier W
    Curr Med Chem; 2012; 19(17):2667-88. PubMed ID: 22455579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications.
    Hu A; Wilson JJ
    Acc Chem Res; 2022 Mar; 55(6):904-915. PubMed ID: 35230803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiometal complexes: characterization and relevant in vitro studies.
    Jurisson S; Cutler C; Smith SV
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):222-34. PubMed ID: 18480740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (99m)Tc and (111)In-labeling of small biomolecules: bifunctional chelators and related coordination chemistry.
    Chakraborty S; Liu S
    Curr Top Med Chem; 2010; 10(11):1113-34. PubMed ID: 20388113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.
    Boros E; Holland JP
    J Labelled Comp Radiopharm; 2018 Jul; 61(9):652-671. PubMed ID: 29230857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.
    Wilbur DS
    Curr Radiopharm; 2011 Jul; 4(3):214-47. PubMed ID: 22201710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic radiopharmaceutical chemistry of oxine.
    Southcott L; Orvig C
    Dalton Trans; 2021 Nov; 50(45):16451-16458. PubMed ID: 34709268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy.
    Kostelnik TI; Orvig C
    Chem Rev; 2019 Jan; 119(2):902-956. PubMed ID: 30379537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition and Post-Transition Radiometals for PET Imaging and Radiotherapy.
    Ramogida C; Price E
    Methods Mol Biol; 2024; 2729():65-101. PubMed ID: 38006492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current State of Targeted Radiometal-Based Constructs for the Detection and Treatment of Disease in the Brain.
    Phipps MD; Sanders VA; Deri MA
    Bioconjug Chem; 2021 Jul; 32(7):1331-1347. PubMed ID: 34015928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals.
    DeGraffenreid AJ; Feng Y; Barnes CL; Ketring AR; Cutler CS; Jurisson SS
    Nucl Med Biol; 2016 May; 43(5):288-95. PubMed ID: 27150031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper radionuclides and radiopharmaceuticals in nuclear medicine.
    Blower PJ; Lewis JS; Zweit J
    Nucl Med Biol; 1996 Nov; 23(8):957-80. PubMed ID: 9004284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiometal chelators for infection diagnostics.
    Akter A; Lyons O; Mehra V; Isenman H; Abbate V
    Front Nucl Med; 2023 Jan; 2():1058388. PubMed ID: 37388440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-induced production and robust radiochemical separation of
    Chakravarty R; Banerjee D; Chakraborty S
    Appl Radiat Isot; 2023 Sep; 199():110921. PubMed ID: 37413711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O
    Carbo-Bague I; Saini S; Cingoranelli SJ; Davey PRWJ; Tosato M; Lapi SE; Ramogida CF
    Nucl Med Biol; 2024; 128-129():108872. PubMed ID: 38262310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiometals for imaging and theranostics, current production, and future perspectives.
    Mikolajczak R; van der Meulen NP; Lapi SE
    J Labelled Comp Radiopharm; 2019 Aug; 62(10):615-634. PubMed ID: 31137083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Study of a Decadentate Acyclic Chelate, HOPO-O
    Carbo-Bague I; Li C; McNeil BL; Gao Y; McDonagh AW; Van de Voorde M; Ooms M; Kunz P; Yang H; Radchenko V; Schreckenbach G; Ramogida CF
    Inorg Chem; 2023 Dec; 62(50):20549-20566. PubMed ID: 36608341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.